Mehmet Samur
0000-0002-9978-5682
Dana Farber Cancer Institute
4 papers found
Refreshing results…
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors
IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM
Missing publications? Search for publications with a matching author name.